InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
3
T+90 hit rate
43%
T+90 mean return
-0.3%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by PATUSKY CHRISTOPHER, Director. Director active across 1 company, notably UNITED THERAPEUTICS Corp. Cumulatively, 30 filings have been published. Breakdown: 1 buy · 3 sells. Total volume traded: €1.1m. History available since 6 May 2021. The latest transaction was disclosed on 19 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations30 total
5,000 shares@ US$175.4315.2% of flowCommon StockSEC:0001562180-25-002636:0
5,000 shares@ US$175.4316.1% of flowCommon StockSEC:0001562180-25-000328:0
700 shares@ US$175.432.1% of flowCommon StockSEC:0001415889-24-022908:0
900 shares0Common StockSEC:0001415889-24-019551:0
2,000 shares@ US$76.362.7% of flowCommon StockSEC:0001415889-24-017414:0
1,310 shares@ US$76.261.7% of flowCommon StockSEC:0001415889-24-013238:0
1,680 shares@ US$224.006.6% of flowCommon StockSEC:0001415889-24-005245:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-014891:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-012408:0
2,000 shares@ US$88.033.0% of flowCommon StockSEC:0001415889-23-007817:0
3 shares@ US$130.240.0% of flowCommon StockSEC:0001104659-23-055524:0
Ideal exit: 13 Apr 2018 (T+270)
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-005017:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-000308:0
1,500 shares@ US$88.032.4% of flowCommon StockSEC:0001415889-22-011591:0
1,500 shares@ US$63.901.8% of flowCommon StockSEC:0001415889-22-008821:0
2,000 shares@ US$63.900.0005% mcap6.4% of flowCommon StockSEC:0001415889-22-005241:0
2,000 shares@ US$63.900.0005% mcap6.2% of flowCommon StockSEC:0001415889-22-003960:0
2,000 shares@ US$88.030.0007% mcap8.5% of flowCommon StockSEC:0001415889-22-003051:0
2,000 shares@ US$63.900.0005% mcap5.9% of flowCommon StockSEC:0001127602-21-028989:0
2,000 shares@ US$63.900.0005% mcap14.8% of flowCommon StockSEC:0001127602-21-028989
2,300 shares@ US$200.160.0016% mcap21.0% of flowCommon StockSEC:0001127602-21-028600:0
2,300 shares@ US$200.160.0016% mcap53.1% of flowCommon StockSEC:0001127602-21-028600
2,000 shares@ US$63.900.0004% mcap5.7% of flowCommon StockSEC:0001127602-21-023280:0
2,000 shares@ US$63.902.0% of flowCommon StockSEC:0001127602-21-023280
1,680 shares0Common StockSEC:0001127602-21-020804:0
25 of 30 declarations
About PATUSKY CHRISTOPHER
Christopher Patusky is a Board Member at United Therapeutics Corp. He plays a key role in overseeing operations and strategic decision-making. His experience in the healthcare sector is an asset for the development of the organization.
